Radiolabeled oligonucleotides for antisense imaging

Abstract

Oligonucleotides radiolabeled with isotopes emitting γ-rays (for SPECT imaging) or positrons (for PET imaging) can be useful for targeting messenger RNA (mRNA) thereby serving as non-invasive imaging tools for detection of gene expression in vivo (antisense imaging). Radiolabeled oligonucleotides may also be used for monitoring their in vivo fate, thereby helping us better understand the barriers to its delivery for antisense targeting. These developments have led to a new area of molecular imaging and targeting, utilizing radiolabeled antisense oligonucleotides. However, the success of antisense imaging relies heavily on overcoming the barriers for its targeted delivery in vivo. Furthermore, the low ability of the radiolabeled antisense oligonucleotide to subsequently internalize into the cell and hybridize with its target mRNA poses additional challenges in realizing its potentials. This review covers the advances in the antisense imaging probe development for PET and SPECT, with an emphasis on radiolabeling strategies, stability, delivery and in vivo targeting.

Figure 1

Chemical structures of DNA, RNA and their synthetic analogues. Figure legends: 1) DNA; 2) Phosphorothioate DNA; 3) Phosphoramidate DNA; 4) Peptide nucleic acid (PNA); 5) RNA; 6) 2′-methoxyethyl RNA; 7) Diethylenimide oxide-tetrahydro-1,4-oxazine (morpholino) oligomer; 8)Locked nucleic acid (LNA).

Figure 2

Chemical structure of bifunctional chelators used for radiolabeling ^99mTc.